Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone for OCD
NCT05624528Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jun 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolcapone in obsessive compulsive disorder (OCD), sponsored by University of Chicago. Started Jun 2023; status: completed.
02
Drugs
tolcapone
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT05624528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05624528.